Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study

Fertility and Sterility
M C PikeAnna H Wu

Abstract

To examine the influence of hormone-related factors on the risk of invasive epithelial ovarian cancer (ovarian cancer). Population-based case-control study using in-person interviews. Academic department of preventive medicine. Four hundred seventy-seven ovarian cancer patients and 660 controls. None. Numbers of and ages at births, oral contraceptive use, and use of menopausal hormone therapy. Compared with nulliparous women, women whose only (last) birth was after age 35 years had an estimated 51% (95% confidence interval: 21%-70%) reduction in risk. If this birth occurred earlier, the reduction in risk was progressively less. Additional (earlier) births reduced the risk further. Oral contraceptive use also reduced risk. Increased body mass index increased risk, but this effect was confined to localized disease and is likely to be a diagnostic bias, as a consequence of other problems associated with being overweight and in itself having no etiological significance. If the major protective effect of a late birth can be confirmed, our most challenging task will be to understand the mechanism to develop a chemoprevention approach to exploit this finding.

References

Jul 28, 1979·Lancet·J T CasagrandeB E Henderson
Sep 1, 1977·British Journal of Preventive & Social Medicine·M L NewhouseH S Shannon
Jan 1, 1987·Journal of Chronic Diseases·M C Pike
Mar 12, 1987·The New England Journal of Medicine·UNKNOWN Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Dev
Nov 1, 1972·Obstetrical & Gynecological Survey·M F Fathalla
Dec 15, 1993·JAMA : the Journal of the American Medical Association·S E HankinsonF E Speizer
Nov 1, 1996·Gynecologic Oncology·H A Risch
Aug 6, 1997·Journal of the National Cancer Institute·M C PikeT M Mack
Nov 5, 1997·Current Opinion in Oncology·L L McCluskey, L Dubeau
Oct 17, 1998·Journal of the Society for Gynecologic Investigation·G C RodriguezC L Hughes
Oct 3, 1999·British Journal of Cancer·D M PurdieA C Green
Apr 29, 2000·Journal of Clinical Epidemiology·S S CoughlinN C Lee
Mar 10, 2001·British Journal of Cancer·L Titus-ErnstoffE R Greenberg
Mar 23, 2001·JAMA : the Journal of the American Medical Association·C RodriguezM J Thun
Jun 30, 2001·Obstetrics and Gynecology·J M SchildkrautA S Whittemore
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·J RoyarJ Chang-Claude
Jan 5, 2002·Journal of the National Cancer Institute·Joellen M SchildkrautGustavo C Rodriguez
Jan 5, 2002·Journal of the National Cancer Institute·Gustavo C RodriguezClaude L Hughes
Apr 4, 2002·Journal of the National Cancer Institute·Tomas RimanIngemar R Persson
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Annekatrin LukanovaRudolf Kaaks
Jul 16, 2002·JAMA : the Journal of the American Medical Association·James V LaceyCatherine Schairer
Aug 2, 2002·Obstetrics and Gynecology·Kathleen M FairfieldSusan E Hankinson
Aug 16, 2002·American Journal of Epidemiology·Tomas RimanIngemar R Persson
Jan 11, 2003·American Journal of Epidemiology·F LubinB Modan
Mar 5, 2003·American Journal of Epidemiology·Leo J SchoutenPiet A van den Brandt
Aug 21, 2003·Journal of the National Cancer Institute·Anders EngelandTone Bjørge

❮ Previous
Next ❯

Citations

Feb 12, 2008·Cancer Causes & Control : CCC·Karen J WernliKathleen M Egan
Jul 1, 2009·Cancer Causes & Control : CCC·Ruth M PfeifferLouise A Brinton
Apr 15, 2005·Cancer Detection and Prevention·Paul K MillsDavid F Goldsmith
Mar 1, 2012·The Lancet Oncology·Celeste Leigh PearceUNKNOWN Ovarian Cancer Association Consortium
Mar 23, 2011·Human Molecular Genetics·Celeste Leigh PearceAnna H Wu
Jun 15, 2010·Human Reproduction Update·D CibulaL Dusek
Jul 17, 2010·Human Reproduction Update·D CibulaL Dusek
Jan 6, 2005·Journal of the National Cancer Institute·Celeste Leigh PearceMalcolm C Pike
Oct 5, 2006·Journal of the National Cancer Institute·James V LaceyPatricia Hartge
May 16, 2009·Cancer Nursing·Monica R McLemoreMarylin J Dodd
Feb 13, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·C-Y YangH-F Chiu
Mar 12, 2009·Cancer Research·Joellen M SchildkrautUNKNOWN Australian Ovarian Cancer Study Group
Dec 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rachel T PalmieriUNKNOWN Australian Ovarian Cancer Study Group
Feb 26, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kathleen A O'ConnorMaxine Weinstein
May 17, 2012·Journal of Ovarian Research·Megan S RiceShelley S Tworoger
May 19, 2012·PLoS Medicine·UNKNOWN Collaborative Group on Epidemiological Studies of Ovarian Cancer
May 22, 2009·Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies·Sharon E JohnattyGeorgia Chenevix-Trench
Oct 10, 2012·Endocrine-related Cancer·Francesmary ModugnoSteffi Oesterreich
Feb 14, 2013·Endocrine-related Cancer·Catherine M OlsenUNKNOWN Ovarian Cancer Association Consortium
Aug 1, 2008·Endocrine-related Cancer·Marc T GoodmanMichael E Carney
Feb 13, 2014·British Journal of Cancer·H S KimY S Song
Mar 28, 2008·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Fariba SalehiBarbara C Vanderhyden
Mar 5, 2013·Cancer Causes & Control : CCC·Mette T FaberUNKNOWN Ovarian Cancer Association Consortium
Mar 7, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Celeste Leigh PearceUNKNOWN Ovarian Cancer Association Consortium
Jan 29, 2008·Gynecologic Oncology·Bo ZhouBin Wang
Dec 7, 2007·Obstetrics and Gynecology Clinics of North America·Christine Vo, Michael E Carney
Jan 16, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Catherine M OlsenPenelope M Webb
Jan 18, 2006·Journal of Thrombosis and Haemostasis : JTH·T SimonUNKNOWN EStrogen and THromboEmbolism Risk (ESTHER) Study Group
Apr 14, 2006·Basic & Clinical Pharmacology & Toxicology·Leslie Bernstein
Sep 14, 2011·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Te-Fu ChanChun-Yuh Yang
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Janet S HildebrandAlpa V Patel
Oct 10, 2006·Annals of Epidemiology·James V LaceyCatherine Schairer
Jul 8, 2015·British Journal of Cancer·C M NagleUNKNOWN Ovarian Cancer Association Consortium
Dec 22, 2014·Gynecologic Oncology·Alice W LeeCeleste Leigh Pearce
Aug 7, 2012·The Lancet Oncology·UNKNOWN Collaborative Group on Epidemiological Studies of Ovarian CancerR Peto
Jul 16, 2016·International Journal of Cancer. Journal International Du Cancer·Alice W LeeUNKNOWN Ovarian Cancer Association Consortium
Oct 5, 2016·American Journal of Epidemiology·Merlise A ClydeUNKNOWN , on behalf of the Ovarian Cancer Association Consortium
Oct 23, 2015·Japanese Journal of Clinical Oncology·Zhen LiuQing-Bao Tian
Nov 26, 2016·Nature Reviews. Cancer·Anthony N KarnezisDavid G Huntsman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.